Grant ID RP210105
Awarded On August 18, 2021
Title Targeting lymphotoxin beta receptor in sensory neurons for control of chemotherapy-induced neuropathic pain
Program Academic Research
Award Mechanism High Impact/High Risk
Institution/Organization The University of Texas Health Science Center at San Antonio
Principal Investigator/Program Director Alexei Tumanov
Cancer Sites All Sites
Contracted Amount $249,996*

*Pending contract negotiation

Lay Summary

Chemotherapy-induced peripheral neuropathy (CIPN) is the most unwanted aspect of chemotherapy during cancer treatment. Painful CIPN not only affects patients’ quality of life, but often leads to termination of life saving chemotherapy. Currently there is no therapeutic strategies to prevent painful CIPN development. The conventionally used opioids and antidepressants have limited success. Hence, it is crucial to reveal mechanisms controlling development of painful CIPN. We revealed a novel immune regulator, lymphotoxin beta receptor (LTbR) as critical molecule controlling the development of CIPN pain in mice. Importantly, pharmacological inhibition of LTbR prevented the development of CIPN p...

Read More